Alliança Saúde e Participações Balance Sheet Health
Financial Health criteria checks 3/6
Alliança Saúde e Participações has a total shareholder equity of R$1.1B and total debt of R$665.6M, which brings its debt-to-equity ratio to 59.7%. Its total assets and total liabilities are R$2.9B and R$1.7B respectively. Alliança Saúde e Participações's EBIT is R$130.4M making its interest coverage ratio 0.7. It has cash and short-term investments of R$122.3M.
Key information
59.70%
Debt to equity ratio
R$665.55m
Debt
| Interest coverage ratio | 0.7x |
| Cash | R$122.27m |
| Equity | R$1.11b |
| Total liabilities | R$1.74b |
| Total assets | R$2.86b |
Recent financial health updates
Alliança Saúde e Participações (BVMF:AALR3) Seems To Use Debt Quite Sensibly
Feb 22
Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06
Recent updates
Some Alliança Saúde e Participações S.A. (BVMF:AALR3) Shareholders Look For Exit As Shares Take 31% Pounding
May 04Return Trends At Alliança Saúde e Participações (BVMF:AALR3) Aren't Appealing
Apr 23Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Price Boost Is Out Of Tune With Revenues
Mar 13Alliança Saúde e Participações (BVMF:AALR3) Seems To Use Debt Quite Sensibly
Feb 22There's Reason For Concern Over Alliança Saúde e Participações S.A.'s (BVMF:AALR3) Massive 37% Price Jump
Jan 26Alliança Saúde e Participações (BVMF:AALR3) Could Be Struggling To Allocate Capital
Dec 31Risks Still Elevated At These Prices As Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Dive 26%
Dec 05Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Aug 25Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking
Jul 11What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You
Apr 17Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around
Aug 17Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching
Jul 08Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?
Apr 05Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years
Mar 10Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?
Feb 17What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?
Jan 27Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?
Dec 11Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?
Aug 07Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Jul 20Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?
Jul 03Financial Position Analysis
Short Term Liabilities: AALR3's short term assets (R$734.4M) do not cover its short term liabilities (R$747.0M).
Long Term Liabilities: AALR3's short term assets (R$734.4M) do not cover its long term liabilities (R$997.1M).
Debt to Equity History and Analysis
Debt Level: AALR3's net debt to equity ratio (48.7%) is considered high.
Reducing Debt: AALR3's debt to equity ratio has reduced from 63.5% to 59.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AALR3 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AALR3 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 30.5% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/28 07:26 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alliança Saúde e Participações S.A. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pedro Mariani | BofA Global Research |
| Carlos Palhares Sequeira | BTG Pactual |
| Giovana Scottini | Eleven Financial Research |